Saving lifes was one of my main aspect to invest in Cytodyn, the other bigger point is, when leronlimab will get a chance to serve 390 patients with might the best in class outcome and approval afterwards ?

This ease all other approval right away - they can't stop giving HIV BLA or cancer treatments with that kind of safe protocoll with nearly no side effects!

This can be huge advantage and accelerate all platform diseases of Cytodyn's Leronlimab!

I really hope so.